If you’re researching how to sell a med spa, you’re probably not ready to list it tomorrow. You’re trying to understand the landscape before you make a decision — what your practice is worth, who’s actually buying, how the process works, and what you stand to lose if you get it wrong. That’s the right instinct, and this guide is built to answer it in full.
Whether you think of it as selling your aesthetic clinic, your medical spa, or your practice, the underlying process — and the mistakes that cost owners real money — is the same. Below is a complete roadmap for how to sell a medical aesthetics practice: who buys these practices, what a realistic timeline looks like, how valuation and deal structure actually work, the compliance issues specific to this industry, and how to protect the staff and clients you’ve spent years building trust with.
You don’t have to sell tomorrow — but you should know how buyers think today.
Before you can think seriously about selling a med spa, you need to understand who’s on the other side of the table. Search “med spa for sale” or “medical spa for sale” today and you’ll find listings spanning all four buyer types below — and the type of buyer you attract changes the deal structure, the price, and what happens to your team after close.
Individual operators. A physician, nurse practitioner, or existing med spa owner buying a single location to operate directly or add to a small footprint. These deals tend to be simpler — often a straightforward asset purchase — but the buyer pool is smaller, and individual buyers frequently rely on SBA or conventional bank financing (see the SBA’s 7(a) loan program for how acquisition financing typically works), which can introduce delays or financing contingencies into your timeline.
Management Services Organizations (MSOs). An MSO structure separates the clinical and business sides of the practice: a licensed provider retains clinical control while the MSO handles marketing, operations, HR, and finance. This is the dominant acquisition vehicle in states with strict corporate practice of medicine (CPOM) restrictions, California being the clearest example. If you’re selling in a CPOM state, you will almost certainly be negotiating with or through an MSO structure.
Private equity platforms. PE-backed med spa platforms are actively acquiring across the country. An estimated 3–4% of med spas nationally are PE-consolidated, with more than 30 active platforms competing for acquisitions. Named active platform sponsors include Princeton Medspa Partners (backed by BC Partners, deployed roughly $120M), AYA Medical Spa, Shore Capital, VSS Capital, and Eagle Merchant Partners. Platforms typically pay a premium multiple for practices that fit their thesis — see Why Private Equity Firms Buy Medical Aesthetics Practices for what they’re actually screening for.
Strategic buyers. Larger regional or national med spa groups, dermatology-adjacent platforms, or wellness/aesthetics brands looking to expand density in a market. Strategic buyers often value geographic fit and brand alignment as much as pure financials.
Each buyer type also determines how you’ll be found. A publicly listed “medical spa for sale” post favors individual operators actively browsing marketplaces. MSO, PE platform, and strategic buyers are reached through a curated, confidential outreach process — one that protects your information from staff, landlords, and competitors while you’re still exploring, not committed.
Valuation is the question every owner asks first, and it deserves a straight answer, not a guess.
Med spa and medical aesthetics valuations are driven primarily by adjusted EBITDA (or seller’s discretionary earnings for smaller practices) multiplied by a market multiple that varies with size, growth, and — most of all — how dependent the practice is on you personally. Owner-dependency is the single largest driver of where your practice lands in its valuation range. A practice that runs smoothly with you on vacation for two weeks is worth meaningfully more, multiple-for-multiple, than one that stalls the moment you’re not in the building.
Recurring revenue matters too. Practices with strong membership programs, subscription-based treatment plans, or high rebooking rates on core procedures are viewed by buyers as lower-risk, and that shows up directly in the multiple they’re willing to pay.
We cover the full valuation methodology, the calculator, and the add-backs most owners miss in Med Spa & Medical Aesthetics Valuation: What Actually Drives Value, and the specific multiple ranges by size band in Med Spa EBITDA Multiples — What Aesthetic Practices Actually Sell For. At a high level: standalone practices typically trade in the 5x–9x EBITDA range depending on size and infrastructure, while practices acquired into an existing platform can see multiple arbitrage up toward 10x–14x — the platform pays more because the practice is worth more inside a larger, more efficient structure.
If you’re asking how much can I sell my med spa for before reading further, our Med Spa Valuation Calculator gives a data-backed estimate in about 60 seconds.
There is no single timeline that fits every deal, but a disciplined, well-run sale process for a medical aesthetics practice typically runs six to nine months from engagement to close — sometimes longer if financing, licensing transfers, or CPOM/MSO restructuring is involved. Owners who prepare in advance move faster and see fewer surprises in diligence. Owners who start reactively — after receiving an unsolicited offer, for example — often move slower, because the preparation work has to happen mid-process instead of beforehand.
| Phase | Typical Duration | What Happens |
|---|---|---|
| Preparation & financial modeling | 4–8 weeks | Adjusted EBITDA build, add-back documentation, buyer materials |
| Buyer outreach & marketing | 6–10 weeks | Confidential buyer mix strategy, curated outreach, initial interest |
| LOI negotiation | 2–4 weeks | Term-sheet comparison, structure negotiation, buyer selection |
| Due diligence | 8–12 weeks | Financial, legal, operational, and compliance review |
| Closing & transition | 2–6 weeks | Definitive agreement, funding, licensing transfer, staff communication |
If you’re 12–24 months out and wondering when to sell my med spa is even the right question yet, How to Prepare Your Medical Aesthetics Practice for a Successful Sale walks through exactly what to fix first.
There’s a lot of conflicting advice online about the best way to sell a med spa. Some of it applies to selling a house. Almost none of it accounts for CPOM restrictions, injectable-supervision compliance, or how PE platforms actually evaluate practices. Here’s what the steps to sell a med spa look like when the process is run properly — and it’s largely the same whether you’re learning how to sell a medical spa in a single state or how to sell a medical aesthetics practice with multiple locations.
Before you talk to a single buyer, your financials need to reflect what the practice actually earns — not what your tax return shows. This means normalizing owner compensation, identifying legitimate add-backs (one-time expenses, above-market owner salary, personal expenses run through the business), and building a clean model a buyer’s diligence team won’t poke holes in. Rushing this step is one of the most common reasons a deal reprices mid-process.
Not every buyer is the right buyer. A curated mix — matching your size, growth stage, and geography against individual operators, MSOs, PE platforms, and strategics — determines how much leverage you have and what kind of deal terms you can push for.
This is where a business broker approach (“list and hope”) and a disciplined M&A process diverge sharply. A broker-listed med spa for sale is visible to your staff, your landlord, and your competitors. A confidential, curated outreach process protects that information while still generating competitive tension among qualified buyers.
Once interested buyers surface, you’ll receive one or more LOIs — non-binding but directionally important documents outlining price, structure, and key terms. This is where representation matters most: an LOI that looks generous on price can hide unfavorable structure, a long exclusivity period, or vague working-capital terms (see the full breakdown of deal structures below).
Buyers will examine your financials, patient/client concentration, provider agreements, payer and membership contracts, compliance history, lease terms, and — critically for this industry — your injectable-supervision and CPOM/MSO documentation, per American Med Spa Association compliance guidance. Anything undocumented here becomes a negotiating point against you.
Asset sale vs. stock sale, earnouts, rollover equity, escrow holdbacks — the structure of your deal often matters as much as the headline price. This is also the stage where staff retention, transition timelines, and post-close role commitments get formalized in writing. See Med Spa Deal Structures Explained for the full glossary.
Funding, licensing transfers, staff communication planning, and — if you’re rolling equity into a platform — your ongoing role post-close. A well-planned transition protects the client relationships and staff continuity that made the practice valuable in the first place.
One of the most overlooked parts of how to sell a med spa is that the practice still has to perform while the process is underway. A buyer’s diligence team will look closely at your trailing months, and any dip in revenue, client retention, or provider stability during the sale process becomes a negotiating point against you.
Most first-time sellers assume “sale price” is the only number that matters. It isn’t. The same headline number can mean very different outcomes depending on structure:
Every one of these terms needs to be understood before you sign an LOI, not after. The full breakdown is in Med Spa Deal Structures Explained: Asset vs. Stock, Earnouts & Rollover Equity.
Medical aesthetics sits in a regulatory gray zone that pure wellness businesses don’t have to navigate. In states with corporate practice of medicine (CPOM) restrictions — California is the most commonly cited example — a non-licensed buyer generally cannot directly own the clinical entity. This is why the MSO model exists: a licensed physician or nurse practitioner retains ownership and clinical authority over the practice entity, while a separate management company (which can be owned by non-clinicians, including PE investors) holds the business operations, brand, and non-clinical assets under a management services agreement.
This split structure affects how a deal is priced and papered. Instead of a single purchase agreement, a CPOM-state transaction often involves a management services agreement, a separate clinical practice transfer, and careful attention to who actually controls clinical decision-making on paper versus in practice. State-by-state ownership rules are tracked in detail by the American Med Spa Association’s legal summaries. Buyers experienced as a med spa m&a advisor or PE platform navigate this routinely; individual buyers unfamiliar with CPOM sometimes stall deals here.
If your practice performs injectable treatments — Botox, dermal fillers, and similar procedures — buyers will also scrutinize your physician-supervision and delegation documentation closely during diligence. Clean compliance history is one of the diligence areas most likely to slow down or reprice a deal if it isn’t in order before you go to market.
Selling the practice you built raises questions that go beyond the financials: What happens to your team? Will your clients feel like they’ve been “sold”? Does the buyer understand what makes your brand work, or are they learning on your practice?
These are legitimate concerns, and they’re addressable — but only if they’re negotiated into the deal, not assumed:
These terms are far easier to negotiate when you have leverage from a competitive process involving multiple buyers than after you’ve already signed with the only buyer you talked to.
Medical aesthetics has a few structural quirks that don’t show up the same way in other healthcare M&A verticals:
None of this makes selling a med spa harder than selling any other healthcare business — but generalist business brokers, and even generalist M&A firms without aesthetics-specific experience, can miss things that materially affect your outcome. A buyer’s diligence team that has reviewed dozens of med spa transactions knows exactly where device financing, membership deferred revenue, and injectable-supervision gaps tend to hide. An advisor who has seen the same patterns can help you get ahead of them before a buyer finds them first.
There’s also a financing dimension worth understanding from the buyer’s side, because it shapes how offers are structured. Individual buyers using SBA financing are often capped by lender appetite for goodwill-heavy purchase prices, which can push them toward a lower headline price offset by other terms. PE platforms and strategic buyers typically pay in a mix of cash at close, rollover equity, and sometimes an earnout — understanding which buyer type is offering which structure helps you compare LOIs on an apples-to-apples basis rather than just the top-line number.
You don’t legally need one. But there’s a meaningful difference between a med spa broker (or medical aesthetics broker) who lists your practice and waits, and a dedicated med spa m&a advisor who runs a disciplined, confidential, auction-style process on your behalf. Understanding this distinction is often the single most consequential part of learning how to sell a med spa well.
| Business Broker | M&A Advisor | |
|---|---|---|
| Approach | Lists publicly, waits for inbound interest | Curated, confidential outreach to targeted buyers |
| Confidentiality | Often visible to staff, landlords, competitors | Protected until you choose to engage |
| Buyer competition | Typically one buyer at a time | Multiple qualified buyers, competitive tension |
| Deal structure guidance | Limited | Active negotiation on price and structure |
| Involvement through close | Often ends at introduction | Senior-level involvement through funding and transition |
At Olympic M&A, we run engagements on a success-fee basis: we only get paid when you do, which means our incentives are aligned with getting you the best outcome, not the fastest one. Whether you’re evaluating an unsolicited offer or just starting to think about when to sell my med spa, our process is built around preparation, clarity, and execution — not pressure.
Learning how to sell a med spa isn’t about finding a single buyer fast — it’s about understanding your options, preparing your financials, and running a process disciplined enough to create real competitive tension. Owners who treat the sale as a project to prepare for, rather than an event to react to, consistently end up with stronger terms and a smoother transition for the team and clients they care about.
Want a number first? Med Spa & Medical Aesthetics Valuation: What Actually Drives Value
Want to know what practices are actually selling for? Med Spa EBITDA Multiples — What Aesthetic Practices Actually Sell For
Curious why PE is so active in this space? Why Private Equity Firms Buy Medical Aesthetics Practices
12–24 months out and want to prepare? How to Prepare Your Medical Aesthetics Practice for a Successful Sale
Already received an offer? Crucial Mistakes to Avoid When Selling Your Medical Aesthetics Practice
Weighing a full sale against joining a platform? The Evolution of Consolidation in Medical Aesthetics
Want to understand deal terms before you negotiate? Med Spa Deal Structures Explained
Want the current state of the market? 2026 Medical Aesthetics M&A Market Update